Literature DB >> 445445

Zinc deficiency and growth of Ehrlich ascites tumor.

D T Minkel, P J Dolhun, B L Calhoun, L A Saryan, D H Petering.   

Abstract

The growth rate of Ehrlich ascites tumors has been examined as a function of the zinc content of the diet of the host mice. Imposition of a diet containing a low amount of zinc (1 microgram/g) on the day of tumor transplant leads to a marked retardation in growth. Pretreatment of the mice with this diet slows the growth further so that the lifetime of the mice can be doubled. Cells in such animals are still viable and rapidly proliferate after the animals are placed on a diet containing zinc. Growth rate of the tumor is also recorded at levels of zinc (40, 80, 160, and 250 microgram/ml) in the drinking water. All of these results are examined in relationship to the zinc in the ascites fluid, which provides the zinc nutriture for the tumor. A direct correlation between growth rate and fluid zinc content is observed. The influence of diet and the tumor upon zinc content of the liver of the host is examined. The results indicate that the tumor essentially sequesters zinc from the animal under zinc-deficient conditions. Over a 10-fold range of fluid zinc values, there are no clear differences in the concentration of zinc within the ascites cells. This occurs despite the facile uptake and efflux of zinc ion by the Ehrlich cell.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445445

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

2.  Kinetic lability of zinc bound to metallothionein in Ehrlich cells.

Authors:  S K Krezoski; J Villalobos; C F Shaw; D H Petering
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

Review 3.  Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy.

Authors:  Mohammad Namdarghanbari; William Wobig; Susan Krezoski; Niloofar M Tabatabai; David H Petering
Journal:  J Biol Inorg Chem       Date:  2011-08-07       Impact factor: 3.358

4.  Tumor-host zinc metabolism the central role of metallothionein.

Authors:  A J Kraker; D H Petering
Journal:  Biol Trace Elem Res       Date:  1983-08       Impact factor: 3.738

5.  Host zinc metabolism and the Ehrlich ascites tumour. Zinc redistribution during tumour-related stress.

Authors:  B Ujjani; G Krakower; G Bachowski; S Krezoski; C F Shaw; D H Petering
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

6.  The role of zinc in 5',5'-diadenosine tetraphosphate production by aminoacyl-transfer RNA synthetases.

Authors:  S Blanquet; P Plateau; A Brevet
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

7.  ESR of copper and iron complexes with antitumor and cytotoxic properties.

Authors:  W E Antholine; B Kalyanaraman; D H Petering
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

Review 8.  Proteomic High Affinity Zn2+ Trafficking: Where Does Metallothionein Fit in?

Authors:  David H Petering; Afsana Mahim
Journal:  Int J Mol Sci       Date:  2017-06-17       Impact factor: 5.923

9.  Induction of hepatic metallothionein I in tumour-bearing mice.

Authors:  D M Kloth; J L Chin; M G Cherian
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.